谭潮, 吴浩, 于乐洋, 严诗婷, 王莹, 田顺平, 周炜, 眭伟, 张转. 预先静脉注射利多卡因预防丙泊酚中/长链脂肪乳注射痛的半数有效量[J]. 实用临床医药杂志, 2022, 26(2): 132-136. DOI: 10.7619/jcmp.20212278
引用本文: 谭潮, 吴浩, 于乐洋, 严诗婷, 王莹, 田顺平, 周炜, 眭伟, 张转. 预先静脉注射利多卡因预防丙泊酚中/长链脂肪乳注射痛的半数有效量[J]. 实用临床医药杂志, 2022, 26(2): 132-136. DOI: 10.7619/jcmp.20212278
TAN Chao, WU Hao, YU Leyang, YAN Shiting, WANG Ying, TIAN Shunping, ZHOU Wei, SUI Wei, ZHANG Zhuan. Median effective dose of intravenous lidocaine in advance in preventing propofol medium/long chain triglyceride emulsion injection-induced pain[J]. Journal of Clinical Medicine in Practice, 2022, 26(2): 132-136. DOI: 10.7619/jcmp.20212278
Citation: TAN Chao, WU Hao, YU Leyang, YAN Shiting, WANG Ying, TIAN Shunping, ZHOU Wei, SUI Wei, ZHANG Zhuan. Median effective dose of intravenous lidocaine in advance in preventing propofol medium/long chain triglyceride emulsion injection-induced pain[J]. Journal of Clinical Medicine in Practice, 2022, 26(2): 132-136. DOI: 10.7619/jcmp.20212278

预先静脉注射利多卡因预防丙泊酚中/长链脂肪乳注射痛的半数有效量

Median effective dose of intravenous lidocaine in advance in preventing propofol medium/long chain triglyceride emulsion injection-induced pain

  • 摘要:
      目的  确定预先静脉注射利多卡因预防丙泊酚中/长链脂肪乳注射痛的半数有效剂量(ED50)。
      方法  选取择期全麻手术患者美国麻醉医师协会(ASA)分别Ⅰ或Ⅱ级。在患者使用丙泊酚中/长链脂肪乳之前,预先静脉注射利多卡因,初始剂量为0.5 mg/kg瘦体质量(LBW)。根据注射痛程度采用Dixon序贯法行利多卡因剂量调整。记录注射痛情况及不良反应发生情况。计算利多卡因的ED50及95%CI。记录麻醉后监测治疗室(PACU)内患者对注射痛的记忆情况并行视觉模拟评分量表(VAS)评估。
      结果  共30例患者完成试验,其中有效止痛患者19例,无效患者11例。预先静脉注射利多卡因预防丙泊酚中/长链脂肪乳注射痛的ED50为0.306 mg/kg(95%CI:0.262~0.357 mg/kg)LBW。90.9%发生注射痛的患者在PACU内对注射痛有记忆,VAS评分为(2.8±1.8)分。
      结论  预先静脉注射利多卡因0.306 mg/kg LBW可有效预防50.0%的择期全麻手术患者丙泊酚中/长链脂肪乳注射痛,且无不良反应。

     

    Abstract:
      Objective  To ensure the median effective dose (ED50) of intravenous lidocaine in advance in preventing propofol medium-/long-chain triglyceride emulsion injection pain.
      Methods  Patients for elective surgery undergoing general anesthesia American Society of Anesthesiologists (ASA) grade Ⅰ or Ⅱwere selected. Lidocaine was administered intravenously prior to propofol medium-/long-chain triglyceride at an initial dose of 0.5 mg/kg lean body mass (LBW). The dose of lidocaine was adjusted by Dixon sequential method according to injection pain. Injection pain and adverse reactions were recorded. The ED50 and 95%CI of lidocaine were calculated. Patients'memory of injection pain in postanesthesia care unit (PACU) was recorded and Visual Analogue Scale (VAS) was evaluated.
      Results  A total of 30 patients completed the trial, including 19 patients with effective pain relief and 11 patients with ineffective pain relief. The ED50 of lidocaine in advance to prevent propofol medium-/long-chain triglyceride emulsion injection pain was 0.306 mg/kg (95%CI, 0.262 to 0.357 mg/kg) LBW. In PACU, 90.9% of the pain-experienced patients had memory of injection pain, and VAS score was (2.8±1.8).
      Conclusion  Prophylactic intravenous lidocaine for 0.306 mg/kg LBW could effectively prevent propofol medium-/long-chain triglyceride emulsion injection pain in 50.0% of patients for elective surgery undergoing general anesthesia without adverse reactions occurred.

     

/

返回文章
返回